Brett R. Blackman
Corporate Officer/Principal at University of Virginia
Profile
Brett R.
Blackman was the founder of HemoShear Therapeutics, Inc. founded in 2008, where he held the title of Director & Chief Scientific Officer from 2008 to 2015.
Currently, he is an Associate Professor at the University of Virginia, and a Member of both the American Heart Association, Inc. and the Robert M Berne Cardiovascular Research Center.
Dr. Blackman's former jobs include Senior Vice President-Research at Evelo Biosciences, Inc. in 2016, Chief Scientific Officer at Omega Therapeutics, Inc. from 2018 to 2019, and Chief Scientific Officer at both Cogen Immune Medicine, Inc. and Senda Biosciences, Inc. from 2016 to 2018.
Dr. Blackman's education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Drexel University.
Brett R. Blackman active positions
| Companies | Position | Start |
|---|---|---|
| University of Virginia | Corporate Officer/Principal | 2010-06-22 |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 2010-06-22 |
| Robert M Berne Cardiovascular Research Center | Corporate Officer/Principal | 2010-06-22 |
Former positions of Brett R. Blackman
| Companies | Position | End |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-05-31 |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
| EVELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2016-09-30 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Founder | 2015-07-31 |
Training of Brett R. Blackman
| University of Pennsylvania | Doctorate Degree |
| Drexel University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
| Robert M Berne Cardiovascular Research Center | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Brett R. Blackman